2025
SJR Q2
JCR Q2 · 3,7
OA
5 eşleşen makale
SCIE
Dergi ayrıntısı
NeuroImmunoModulation
- Yayıncı
- S. Karger AG
- Ülke
- Switzerland · Western Europe
- Tür
- journal
- ISSN
-
1021740114230216
Bütünleşik değerlendirme
Scopus tarafı Scimago SJR; WoS tarafı Master Journal List + JCR/JIF. Kaynaklar ISSN üzerinden eşleştirilir. WoS / JCR metrikleri yalnızca 1997 ve sonrası yıllar için vardır.
WoS / JCR verileri 1997 ve sonrası içindir.
Scopus
Scopus · Scimago
- SJR 0,801
- Quartile Q2
- H-Index 78
- Atıf/yayın 3,36
- Doküman (3y) 109
- Atıf (3y) 302
Clarivate
Web of Science · JCR · 2025
- JCR Q Q2
- JIF 3,7
- 5Y JIF 2,6
- JCI 0,55
WoS indeksleri
- SCIE
Konu sınıflandırması
Kategoriler (SJR)
- Endocrine and Autonomic Systems Q3
- Endocrinology Q2
- Immunology Q3
- Neurology Q2
Alanlar
- Biochemistry, Genetics and Molecular Biology
- Immunology and Microbiology
- Neuroscience
WoS kategorileri
- Endocrinology & Metabolism | Immunology | Neurosciences
Yıllık quartile karşılaştırması
Scimago (SJR) tüm yıllar; Clarivate (JCR / JIF / JCI) 1997 ve sonrası. Güncel yıl açık; diğer yıllar kapalıdır.
WoS / JCR verileri 1997 ve sonrası içindir.
| Yıl | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q2 | Q2 | 0,801 | 3,7 | 2,6 | 0,55 | Q3 | 78 |
| 2024 | Q3 | Q3 | 0,653 | 2,5 | 2,2 | 0,53 | Q3 | 76 |
| 2023 | Q3 | Q3 | 0,6 | 2,2 | 2,3 | 0,45 | Q3 | 76 |
| 2022 | Q3 | Q4 | 0,663 | 2,4 | 2,7 | 0,46 | Q3 | 76 |
| 2021 | Q3 | Q3 | 0,548 | 2,8 | 2,6 | 0,42 | Q4 | 76 |
| 2020 | Q3 | Q3 | 0,635 | 2,5 | 2,5 | 0,39 | Q4 | 76 |
| 2019 | Q3 | Q4 | 0,488 | 1,7 | 2,2 | 0,34 | Q4 | 76 |
| 2018 | — | Q4 | — | 1,4 | 1,9 | 0,46 | Q3 | — |
| 2017 | Q2 | Q3 | 1,064 | 2,2 | 2,2 | 0,65 | Q3 | 76 |
| 2016 | Q2 | Q3 | 1,06 | 2,7 | 2,3 | — | — | 76 |
| 2015 | Q2 | Q3 | 0,878 | 2,4 | 2 | — | — | 76 |
| 2014 | Q3 | Q3 | 0,735 | 1,9 | 2,3 | — | — | 76 |
| 2013 | Q2 | Q3 | 0,75 | 1,8 | 2,6 | — | — | 76 |
| 2012 | Q2 | Q3 | 0,848 | 1,8 | 2,4 | — | — | 76 |
| 2011 | Q2 | Q3 | 0,907 | 2,4 | 2,3 | — | — | 76 |
| 2010 | Q2 | Q3 | 0,855 | 2,6 | 2,6 | — | — | 76 |
| 2009 | — | Q3 | — | 2 | 2,2 | — | — | — |
| 2008 | — | Q4 | — | 1,2 | 1,9 | — | — | — |
| 2007 | — | Q3 | — | 1,7 | 1,5 | — | — | — |
| 2006 | — | Q3 | — | 1,8 | — | — | — | — |
| 2005 | — | Q3 | — | 1,5 | — | — | — | — |
| 2004 | — | Q3 | — | 1,9 | — | — | — | — |
| 2003 | — | Q4 | — | 1,1 | — | — | — | — |
| 2002 | — | Q3 | — | 1,2 | — | — | — | — |
| 2001 | — | Q2 | — | 2 | — | — | — | — |
| 2000 | — | Q2 | — | 2,7 | — | — | — | — |
| 1999 | — | Q3 | — | 1,6 | — | — | — | — |
| 1998 | — | Q3 | — | 0,7 | — | — | — | — |
JCR kategori quartile geçmişi
Yıla ve kategoriye göre JCR / JCI quartile. 1997 ve sonrası.
WoS / JCR verileri 1997 ve sonrası içindir.
| Yıl | Kategori | Edition | JCR Q (1997+) | JCI Q (1997+) | Sıra |
|---|---|---|---|---|---|
| 2025 | ENDOCRINOLOGY & METABOLISM | SCIE | Q2 | Q3 | 83/198 |
| 2025 | IMMUNOLOGY | SCIE | Q2 | Q3 | 85/183 |
| 2025 | NEUROSCIENCES | SCIE | Q2 | Q3 | 126/330 |
| 2024 | ENDOCRINOLOGY & METABOLISM | SCIE | Q3 | Q3 | 120/193 |
| 2024 | IMMUNOLOGY | SCIE | Q3 | Q3 | 122/183 |
| 2024 | NEUROSCIENCES | SCIE | Q3 | Q4 | 192/314 |
| 2023 | ENDOCRINOLOGY & METABOLISM | SCIE | Q3 | Q4 | 127/186 |
| 2023 | IMMUNOLOGY | SCIE | Q4 | Q3 | 137/181 |
| 2023 | NEUROSCIENCES | SCIE | Q3 | Q4 | 212/310 |
| 2022 | ENDOCRINOLOGY & METABOLISM | SCIE | Q4 | Q3 | 117/145 |
| 2022 | IMMUNOLOGY | SCIE | Q4 | Q4 | 135/161 |
| 2022 | NEUROSCIENCES | SCIE | Q4 | Q4 | 206/272 |
| 2021 | ENDOCRINOLOGY & METABOLISM | SCIE | Q4 | Q4 | 114/146 |
| 2021 | IMMUNOLOGY | SCIE | Q4 | Q4 | 135/162 |
| 2021 | NEUROSCIENCES | SCIE | Q3 | Q4 | 206/275 |
| 2020 | ENDOCRINOLOGY & METABOLISM | SCIE | Q4 | Q4 | 119/146 |
| 2020 | IMMUNOLOGY | SCIE | Q4 | Q4 | 132/162 |
| 2020 | NEUROSCIENCES | SCIE | Q3 | Q4 | 202/273 |
| 2019 | ENDOCRINOLOGY & METABOLISM | SCIE | Q4 | Q4 | 124/143 |
| 2019 | IMMUNOLOGY | SCIE | Q4 | Q4 | 137/159 |
| 2019 | NEUROSCIENCES | SCIE | Q4 | Q4 | 231/272 |
| 2018 | ENDOCRINOLOGY & METABOLISM | SCIE | Q4 | Q3 | 130/145 |
| 2018 | IMMUNOLOGY | SCIE | Q4 | Q4 | 143/158 |
| 2018 | NEUROSCIENCES | SCIE | Q4 | Q4 | 239/267 |
| 2017 | ENDOCRINOLOGY & METABOLISM | SCIE | Q3 | Q3 | 104/142 |
| 2017 | IMMUNOLOGY | SCIE | Q3 | Q3 | 114/155 |
| 2017 | NEUROSCIENCES | SCIE | Q3 | Q3 | 182/261 |
| 2016 | ENDOCRINOLOGY & METABOLISM | SCIE | Q3 | — | 77/138 |
| 2016 | IMMUNOLOGY | SCIE | Q3 | — | 92/151 |
| 2016 | NEUROSCIENCES | SCIE | Q3 | — | 139/259 |
| 2015 | ENDOCRINOLOGY & METABOLISM | SCIE | Q3 | — | 88/133 |
| 2015 | IMMUNOLOGY | SCIE | Q3 | — | 95/151 |
| 2015 | NEUROSCIENCES | SCIE | Q3 | — | 158/256 |
| 2014 | ENDOCRINOLOGY & METABOLISM | SCIE | Q3 | — | 96/128 |
| 2014 | IMMUNOLOGY | SCIE | Q4 | — | 116/148 |
| 2014 | NEUROSCIENCES | SCIE | Q3 | — | 185/252 |
| 2013 | ENDOCRINOLOGY & METABOLISM | SCIE | Q3 | — | 87/124 |
| 2013 | IMMUNOLOGY | SCIE | Q4 | — | 121/144 |
| 2013 | NEUROSCIENCES | SCIE | Q4 | — | 191/252 |
| 2012 | ENDOCRINOLOGY & METABOLISM | SCIE | Q3 | — | 88/122 |
| 2012 | IMMUNOLOGY | SCIE | Q4 | — | 109/137 |
| 2012 | NEUROSCIENCES | SCIE | Q3 | — | 188/252 |
| 2011 | ENDOCRINOLOGY & METABOLISM | SCIE | Q3 | — | 65/122 |
| 2011 | IMMUNOLOGY | SCIE | Q3 | — | 91/139 |
| 2011 | NEUROSCIENCES | SCIE | Q3 | — | 148/244 |
| 2010 | ENDOCRINOLOGY & METABOLISM | SCIE | Q3 | — | 62/116 |
| 2010 | IMMUNOLOGY | SCIE | Q3 | — | 73/134 |
| 2010 | NEUROSCIENCES | SCIE | Q3 | — | 124/239 |
| 2009 | ENDOCRINOLOGY & METABOLISM | SCIE | Q3 | — | 72/105 |
| 2009 | IMMUNOLOGY | SCIE | Q3 | — | 92/128 |
| 2009 | NEUROSCIENCES | SCIE | Q3 | — | 160/231 |
| 2008 | ENDOCRINOLOGY & METABOLISM | SCIE | Q4 | — | 86/93 |
| 2008 | IMMUNOLOGY | SCIE | Q4 | — | 107/121 |
| 2008 | NEUROSCIENCES | SCIE | Q4 | — | 181/221 |
| 2007 | ENDOCRINOLOGY & METABOLISM | SCIE | Q4 | — | 74/92 |
| 2007 | IMMUNOLOGY | SCIE | Q4 | — | 93/119 |
| 2007 | NEUROSCIENCES | SCIE | Q3 | — | 147/211 |
| 2006 | ENDOCRINOLOGY & METABOLISM | SCIE | Q3 | — | 65/93 |
| 2006 | IMMUNOLOGY | SCIE | Q3 | — | 87/117 |
| 2006 | NEUROSCIENCES | SCIE | Q3 | — | 132/200 |
| 2005 | ENDOCRINOLOGY & METABOLISM | SCIE | Q3 | — | 64/89 |
| 2005 | IMMUNOLOGY | SCIE | Q3 | — | 86/115 |
| 2005 | NEUROSCIENCES | SCIE | Q3 | — | 145/200 |
| 2004 | ENDOCRINOLOGY & METABOLISM | SCIE | Q3 | — | 51/87 |
| 2004 | IMMUNOLOGY | SCIE | Q3 | — | 68/111 |
| 2004 | NEUROSCIENCES | SCIE | Q3 | — | 118/198 |
| 2003 | ENDOCRINOLOGY & METABOLISM | SCIE | Q4 | — | 70/88 |
| 2003 | IMMUNOLOGY | SCIE | Q4 | — | 86/114 |
| 2003 | NEUROSCIENCES | SCIE | Q4 | — | 150/198 |
| 2002 | ENDOCRINOLOGY & METABOLISM | SCIE | Q3 | — | 63/88 |
| 2002 | IMMUNOLOGY | SCIE | Q4 | — | 93/119 |
| 2002 | NEUROSCIENCES | SCIE | Q3 | — | 135/197 |
| 2001 | ENDOCRINOLOGY & METABOLISM | SCIE | Q2 | — | 43/90 |
| 2001 | IMMUNOLOGY | SCIE | Q3 | — | 58/114 |
| 2001 | NEUROSCIENCES | SCIE | Q2 | — | 91/198 |
| 2000 | ENDOCRINOLOGY & METABOLISM | SCIE | Q2 | — | 26/89 |
| 2000 | IMMUNOLOGY | SCIE | Q2 | — | 31/116 |
| 2000 | NEUROSCIENCES | SCIE | Q2 | — | 61/203 |
| 1999 | IMMUNOLOGY | SCIE | Q3 | — | 65/115 |
| 1999 | NEUROSCIENCES | SCIE | Q3 | — | 108/201 |
| 1998 | IMMUNOLOGY | SCIE | Q4 | — | 99/120 |
| 1998 | NEUROSCIENCES | SCIE | Q3 | — | 142/202 |